← Evidence map

ArticlemAbs2025

Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study.

Jennifer Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 39881564